1.Screening of the Cardiac Beta Myosin Heavy Chain Gene for the Linkage to Familial Hypertrophic Cardiomyopathy in a Korean Family.
Jeong Euy PARK ; Cheong Ho YI ; Hae Kyung KIM ; Jeong Won SOHN ; Gil Hong PARK ; Je Ho LEE
Korean Circulation Journal 1994;24(6):819-833
BACKGROUND: Through a genome-wide search using the genetic markers(RFLP genetic markers), the familial hypertrophic cardiomyopathy(FHCM) with an autosomal dominant mode of inheritance has been firstly detected to be genetically linked to chromosome 14q1. The subsequent studies have shown that the point mutations at the exons encoding for the head and head /rod junction of the cardiac beta myosin heavy chain(beta-MHC) are the most frequent type of mutation in the FHCM families genetically implicated with a linkage to beta-MHC, whereas the alpha/beta-MHC hybrid gene and a large deletion at the 3' region of beta-MHC gene were also rarely detected. With the other families genetically implicated with the chromosomes 1,11,15,16 and 18, FHCM also manifests locus heterogeneity, a phenomenon in which abnormalities at different genes are involved in different families. In addition, a korean FHCM family with 403Arg-->Gln mutation of beta-MHC gene has been previously found by an american research group. METHODS: For clinical diagnosis, echocardiography and electrocardiography were performed on the individual members of a korean FHCM family. The microsatellite markers(MYO-I,MYO-II) located in the beta-MHC gene region were amplified by PCR(polymerase chain reaction) and the polymorphism was analyzed for the possible linkage to the phenotypic expression of FHCM. Independently, the same PCR products of the exons 13 and 23 were digested with the specific restriction enzymes for the presence of the most frequently reported point mutations of beta-MHC gene (403 and 908 amino acid mutations). Single strand conformation polymorphism(SSCP) of the exon 13 and 23 of the beta-MHC gene was also analyzed of the mobility shift expected if any point mutation is present at these two exons. RESULTS: The inheritance pattern of HCM(hypertrophic cardiomyopathy) in the family is considered as autosomal dominant. In this family(KU 101), one of the microsatellite markers(MYO-II) indicated the possible cosegregation between the allele was also present in the 32-year-old brother of the proband, who reveals no clinical signs of the disease. The other microsatellite genetic marker(MYO-I) was uninformative, without giving the discriminating power to verify the linkage to beta-MHC gene. In the analysis for two common mutations of beta-MHC gene by PCR-RFLP and PCR-SSCP, no evidence was found for 403 and 908 amino acid mutations and any point mutation in the exons 13 and 23. CONCLUSIONS: Based on the linkage analysis using microsatellite genetic markers, there was a possibility that the disease could be linked to an abnormality in the beta-MHC gene of the chromosome 14q1.
Adult
;
Alleles
;
Cardiomyopathy, Hypertrophic, Familial*
;
Diagnosis
;
Echocardiography
;
Electrocardiography
;
Exons
;
Genetic Markers
;
Head
;
Humans
;
Inheritance Patterns
;
Mass Screening*
;
Microsatellite Repeats
;
Point Mutation
;
Polymerase Chain Reaction
;
Population Characteristics
;
Siblings
;
Ventricular Myosins*
;
Wills
2.Screening of the Cardiac Beta Myosin Heavy Chain Gene for the Linkage to Familial Hypertrophic Cardiomyopathy in a Korean Family.
Jeong Euy PARK ; Cheong Ho YI ; Hae Kyung KIM ; Jeong Won SOHN ; Gil Hong PARK ; Je Ho LEE
Korean Circulation Journal 1994;24(6):819-833
BACKGROUND: Through a genome-wide search using the genetic markers(RFLP genetic markers), the familial hypertrophic cardiomyopathy(FHCM) with an autosomal dominant mode of inheritance has been firstly detected to be genetically linked to chromosome 14q1. The subsequent studies have shown that the point mutations at the exons encoding for the head and head /rod junction of the cardiac beta myosin heavy chain(beta-MHC) are the most frequent type of mutation in the FHCM families genetically implicated with a linkage to beta-MHC, whereas the alpha/beta-MHC hybrid gene and a large deletion at the 3' region of beta-MHC gene were also rarely detected. With the other families genetically implicated with the chromosomes 1,11,15,16 and 18, FHCM also manifests locus heterogeneity, a phenomenon in which abnormalities at different genes are involved in different families. In addition, a korean FHCM family with 403Arg-->Gln mutation of beta-MHC gene has been previously found by an american research group. METHODS: For clinical diagnosis, echocardiography and electrocardiography were performed on the individual members of a korean FHCM family. The microsatellite markers(MYO-I,MYO-II) located in the beta-MHC gene region were amplified by PCR(polymerase chain reaction) and the polymorphism was analyzed for the possible linkage to the phenotypic expression of FHCM. Independently, the same PCR products of the exons 13 and 23 were digested with the specific restriction enzymes for the presence of the most frequently reported point mutations of beta-MHC gene (403 and 908 amino acid mutations). Single strand conformation polymorphism(SSCP) of the exon 13 and 23 of the beta-MHC gene was also analyzed of the mobility shift expected if any point mutation is present at these two exons. RESULTS: The inheritance pattern of HCM(hypertrophic cardiomyopathy) in the family is considered as autosomal dominant. In this family(KU 101), one of the microsatellite markers(MYO-II) indicated the possible cosegregation between the allele was also present in the 32-year-old brother of the proband, who reveals no clinical signs of the disease. The other microsatellite genetic marker(MYO-I) was uninformative, without giving the discriminating power to verify the linkage to beta-MHC gene. In the analysis for two common mutations of beta-MHC gene by PCR-RFLP and PCR-SSCP, no evidence was found for 403 and 908 amino acid mutations and any point mutation in the exons 13 and 23. CONCLUSIONS: Based on the linkage analysis using microsatellite genetic markers, there was a possibility that the disease could be linked to an abnormality in the beta-MHC gene of the chromosome 14q1.
Adult
;
Alleles
;
Cardiomyopathy, Hypertrophic, Familial*
;
Diagnosis
;
Echocardiography
;
Electrocardiography
;
Exons
;
Genetic Markers
;
Head
;
Humans
;
Inheritance Patterns
;
Mass Screening*
;
Microsatellite Repeats
;
Point Mutation
;
Polymerase Chain Reaction
;
Population Characteristics
;
Siblings
;
Ventricular Myosins*
;
Wills
3.Modeling Human Exposure Levels to Airborne Volatile Organic Compounds by the Hebei Spirit Oil Spill.
Jong Ho KIM ; Byoung Kyu KWAK ; Mina HA ; Hae Kwan CHEONG ; Jongheop YI
Environmental Health and Toxicology 2012;27(1):e2012008-
OBJECTIVES: The goal was to model and quantify the atmospheric concentrations of volatile organic compounds (VOCs) as the result of the Hebei Spirit oil spill, and to predict whether the exposure levels were abnormally high or not. METHODS: We developed a model for calculating the airborne concentration of VOCs that are produced in an oil spill accident. The model was applied to a practical situation, namely the Hebei Spirit oil spill. The accuracy of the model was verified by comparing the results with previous observation data. The concentrations were compared with the currently used air quality standards. RESULTS: Evaporation was found to be 10- to 1,000-fold higher than the emissions produced from a surrounding industrial complex. The modeled concentrations for benzene failed to meet current labor environmental standards, and the concentration of benzene, toluene, ortho- meta- para-xylene were higher than the values specified by air quality standards and guideline values on the ocean. The concentrations of total VOCs were much higher than indoor environmental criteria for the entire Taean area for a few days. CONCLUSIONS: The extent of airborne exposure was clearly not the same as that for normal conditions.
Benzene
;
Humans
;
Petroleum Pollution
;
Toluene
;
Volatile Organic Compounds
;
Volatilization
;
Xylenes
4.Eupatilin Inhibits Gastric Cancer Cell Growth by Blocking STAT3-Mediated VEGF Expression.
Jae Ho CHEONG ; Sung Yi HONG ; Yanjun ZHENG ; Sung Hoon NOH
Journal of Gastric Cancer 2011;11(1):16-22
PURPOSE: Eupatilin is an antioxidative flavone and a phytopharmaceutical derived from Artemisia asiatica. It has been reported to possess anti-tumor activity in some types of cancer including gastric cancer. Eupatilin may modulate the angiogenesis pathway which is part of anti-inflammatory effect demonstrated in gastric mucosal injury models. Here we investigated the anti-tumor effects of eupatilin on gastric cancer cells and elucidated the potential underlying mechanism whereby eupatilin suppresses angiogenesis and tumor growth. MATERIALS AND METHODS: The impact of eupatilin on the expression of angiogenesis pathway proteins was assessed using western blots in MKN45 cells. Using a chromatin immunoprecipitation assay, we tested whether eupatilin affects the recruitment of signal transducer and activator of transcription 3 (STAT3), aryl hydrocarbon receptor nuclear translocator (ARNT) and hypoxia-inducible factor-1alpha (HIF-1alpha) to the human VEGF promoter. To investigate the effect of eupatilin on vasculogenesis, tube formation assays were conducted using human umbilical vein endothelial cells (HUVECs). The effect of eupatilin on tumor suppression in mouse xenografts was assessed. RESULTS: Eupatilin significantly reduced VEGF, ARNT and STAT3 expression prominently under hypoxic conditions. The recruitment of STAT3, ARNT and HIF-1alpha to the VEGF promoter was inhibited by eupatilin treatment. HUVECs produced much foreshortened and severely broken tubes with eupatilin treatment. In addition, eupatilin effectively reduced tumor growth in a mouse xenograft model. CONCLUSIONS: Our results indicate that eupatilin inhibits angiogenesis in gastric cancer cells by blocking STAT3 and VEGF expression, suggesting its therapeutic potential in the treatment of gastric cancer.
Animals
;
Artemisia
;
Aryl Hydrocarbon Receptor Nuclear Translocator
;
Blotting, Western
;
Chromatin Immunoprecipitation
;
Flavones
;
Flavonoids
;
Human Umbilical Vein Endothelial Cells
;
Humans
;
Mice
;
Proteins
;
STAT3 Transcription Factor
;
Stomach Neoplasms
;
Transplantation, Heterologous
;
Vascular Endothelial Growth Factor A
5.Efficacy of Preoperative Chemotherapy in a Choroid Plexus Carcinoma.
Cheong Ho NOH ; Jin Seok YI ; Hyung Jin LEE ; Il Woo LEE
Journal of Korean Neurosurgical Society 2004;35(3):309-312
Choroid plexus carcinomas(CPCs) are rare neuroectodermal malginancies occuring mostly in young children of less than two years old, of which prognosis have been reported extremely grave. Generally, the extent of surgical resection has been regarded the most significant prognostic factor. However, the inherent hypervascularity and softness of these tumors make the total removal very difficult. We present our experience in a 18-months-old child with a large intraventricular CPC, of which total resection was achieved by the use of preoperative neoadjuvant chemotherapy with ICE regimen(Ifosfamide, Cisplatinum, Etoposide).
Child
;
Choroid Plexus*
;
Choroid*
;
Drug Therapy*
;
Humans
;
Ice
;
Neural Plate
;
Prognosis
6.Sleep Promoting Effect of Luteolin in Mice via Adenosine A1 and A2A Receptors
Tae Ho KIM ; Raly James CUSTODIO ; Jae Hoon CHEONG ; Hee Jin KIM ; Yi Sook JUNG
Biomolecules & Therapeutics 2019;27(6):584-590
Luteolin, a widespread flavonoid, has been known to have neuroprotective activity against various neurologic diseases such as epilepsy, and Alzheimer’s disease. However, little information is available regarding the hypnotic effect of luteolin. In this study, we evaluated the hypnotic effect of luteolin and its underlying mechanism. In pentobarbital-induced sleeping mice model, luteolin (1, and 3 mg/kg, p.o.) decreased sleep latency and increased the total sleep time. Through electroencephalogram (EEG) and electromyogram (EMG) recording, we demonstrated that luteolin increased non-rapid eye movement (NREM) sleep time and decreased wake time. To evaluate the underlying mechanism, we examined the effects of various pharmacological antagonists on the hypnotic effect of luteolin. The hypnotic effect of 3 mg/kg of luteolin was not affected by flumazenil, a GABAA receptor-benzodiazepine (GABAAR-BDZ) binding site antagonist, and bicuculine, a GABAAR-GABA binding site antagonist. On the other hand, the hypnotic effect of 3 mg/kg of luteolin was almost completely blocked by caffeine, an antagonist for both adenosine A1 and A2A receptor (A1R and A2AR), 8-Cyclopentyl-1,3-dipropylxanthine (DPCPX), an A1R antagonist, and SCH-58261, an A2AR antagonist. From the binding affinity assay, we have found that luteolin significantly binds to not only A1R but also A2AR with IC₅₀ of 1.19, 0.84 μg/kg, respectively. However, luteolin did not bind to either BDZ-receptor or GABAAR. From these results, it has been suggested that luteolin has hypnotic efficacy through A1R and A2AR binding.
Adenosine
;
Animals
;
Binding Sites
;
Caffeine
;
Electroencephalography
;
Epilepsy
;
Eye Movements
;
Flumazenil
;
Hand
;
Hypnotics and Sedatives
;
Luteolin
;
Mice
;
Receptor, Adenosine A1
;
Receptor, Adenosine A2A
;
Sleep Initiation and Maintenance Disorders
7.Five Cases of Orbital Infarction Syndrome Caused by Compression of Surgical Scalp Flap.
Cheong Ho NOH ; Hyung Jin LEE ; Jin Seok YI ; Ji Ho YANG ; Il Woo LEE ; Dal Soo KIM ; Mun Chan KIM
Korean Journal of Cerebrovascular Surgery 2003;5(1):53-57
Orbital infarction syndrome is a rare disorder resulting from ischemia of the intraocular and intraorbital structures due to hypoperfusion of the ophthalmic artery and its branches. The syndrome can occur with common carotid artery occlusion, orbital mucormycosis, giant cell arteritis and complications of surgery and manifests proptosis, ophthalmoplegia, and unilateral blindness. We recently experienced 5 cases of proptosis, ophthalmoplegia and unilateral blindness immediately after operation for 2 years. The cause of orbital infarction syndrome in these cases appeared to be the direct compression of orbit by the tightly retracted frontal scalp flap. We report and discuss possible mechanism with literature review.
Blindness
;
Carotid Artery, Common
;
Exophthalmos
;
Giant Cell Arteritis
;
Infarction*
;
Ischemia
;
Mucormycosis
;
Ophthalmic Artery
;
Ophthalmoplegia
;
Orbit*
;
Scalp*
8.Effect of Percutaneous Vertebroplasty with Polymethylmethacrylate to Osteoporotic Spinal Compression Fractures and Bursting Fractures.
Cheong Ho NOH ; Jin seok YI ; Hyung Jin LEE ; Ji Ho YANG ; Il Woo LEE ; Moon Chan KIM
Journal of Korean Neurosurgical Society 2004;35(4):365-371
OBJECTIVE: The purpose of this study is to determine the efficacy and safety of percutaneous vertebroplasty for patients with osteoporotic spinal bursting fracture. METHODS: The authors reviewed retrospectively 77 patients who underwent percutaneous vertebroplasty for osteoporotic spinal fracture from May 1, 2000 to March 31, 2003. They were divided into simple compression, mild bursting and severe bursting fracture groups. Cause of injury, height loss of fractured vertebra, operation time interval after fracture, injected amount of polymethylmethacrylate, cement leakage and clinical outcome were investigated. RESULTS: Out of 77 patients, 29 cases (38%) were bursting fractures consisted of 23 mild (mean neural canal involvement=11%) and 6 severe cases (42.8%). Out of the 30 bursting fracture levels, bone cement leakages occurred in 15 vertebral levels (50%), which were more common compared with compression fracture (25%). But the improvement of back pain of the bursting fracture patients (83%) was not different from that of compression fracture patients (87%). In compression fractures, cement leakages were more common when vertebroplasty was done at the time of less than 10 days after onset of symptoms compared with more than 10 days. CONCLUSION: Bone cement leakages are more common in bursting fractures than compression fractures. Nonetheless, the complication is not significant and the same clinical improvement could be anticipated. For elderly patients especially those having difficulty in open surgery under general anesthesia due to their condition, percutaneous vertebroplasty may be considered as a therapeutic option.
Aged
;
Anesthesia, General
;
Back Pain
;
Fractures, Compression*
;
Humans
;
Neural Tube
;
Osteoporosis
;
Polymethyl Methacrylate*
;
Retrospective Studies
;
Spinal Fractures
;
Spine
;
Vertebroplasty*
9.Evaluation of the Safety and Feasibility of D2 Lymphadenectomy in Elderly Patients with Gastric Cancer.
Woo Sung KANG ; Oh CHEONG ; Mi Ran JEONG ; Ho Goon KIM ; Sung Yeop RYU ; Yeong Kyu PARK ; Dong Yi KIM ; Young Jin KIM
Journal of the Korean Gastric Cancer Association 2008;8(2):85-90
PURPOSE: The aim of this study was to evaluate the safety and feasibility of D2 lymphadenectomy in elderly patients with gastric cancerby comparing the surgical outcomes and postoperative courses between an elderly group and a control group undergoing the same procedure. MATERIALS AND METHODS: Clinical information was reviewed for 1251 patients with gastric cancer who underwent gastrectomy between May 2004 and May 2007. Patients were classified into the following two groups: an elderly group (older than the average life span in Korea) and a control group (younger than the elderly group). Clinicopathologic features and postoperative courses after D2 lymphadenectomy were reviewed and compared between the two groups. RESULTS: There were a total of 120 (9%) elderly group patients among all those reviewed, and 86 (72.2%) of them underwent D2 lymphadenectomy. There was 27.5% postoperative morbidity in the elderly group, which was significantly different from thecontrol group (12.8%, p=0.003). However, on multivariate analysis, ASA score and combined resection were independent predictive factors of postoperative complications, while age was not predictive. CONCLUSION: Older age is not a predictive factor of postoperative complications in itself, and D2 lymphadenectomy can be safely performed in elderly patients with gastric cancer, provided they have good ASA scores and do not undergo accompanying combined resection.
Aged
;
Gastrectomy
;
Humans
;
Lymph Node Excision
;
Multivariate Analysis
;
Postoperative Complications
;
Stomach Neoplasms
10.Intraperitoneal Bronchogenic Cyst Misidentified as Gastric Submucosal Tumor.
Ho Goon KIM ; Mi Ran JEONG ; Hyo KANG ; Oh CHEONG ; Jae Kyun JU ; Young Kyu PARK ; Seong Yeob RYU ; Dong Yi KIM ; Young Jin KIM
Journal of the Korean Surgical Society 2010;79(2):149-151
Most bronchogenic cysts originate in the mediastinum, while 15% to 20% occur in the lung parenchyma. According to the literature, most intrapulmonary cysts occur in the lower lobes. But, they are rarely located in an extrathoracic site, such as subdiaphragmatic retroperitoneal area. We describe a paraesophageal intra-abdominal bronchogenic cyst, first considered as gastric submucosal tumor. Resection was successfully realized by laparoscopy. A 20-year-old female was admitted to our hospital with incidentally detected gastric submucosal tumor. At operation, there was a 2.5x2 cm sized cystic tumor that was isolated from the gastric wall. We performed tumor resection laparoscopically. The postoperative course was uneventful and the patient was discharged on the second postoperative day. Histological examination reported a bronchogenic cyst. We, herein, report this case.
Bronchogenic Cyst
;
Female
;
Humans
;
Laparoscopy
;
Lung
;
Mediastinum
;
Young Adult